Consultation starts on how to reveal payments from industry to doctorsBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f615 (Published 29 January 2013) Cite this as: BMJ 2013;346:f615
- Nigel Hawkes
A consultation has been launched on the best way to disclose payments made by the drug industry to individual doctors or to other health professionals in the United Kingdom. The likely outcome is a single searchable database, accessible to all, that would list all payments made for whatever purpose and would name the recipients.
Payments would include funding for clinical trials; fees for advice, consultancy, lectures, and educational activity; and the costs of foreign trips to conferences, for example. The drug industry has already announced its intention to disclose the total amounts paid and the number of healthcare professionals who benefited, beginning this spring. …
Log in using your username and password
Log in through your institution
Sign up for a free trial